The tables below indicate the effectiveness of the SCENAR in a wide range of medical conditions. Individual results may vary.

1. Summary Results of 50,000 Cases in Russian Literature Percentage Success Rate by Category

   Circulatory 82% Musculoskeletal 79% Respiratory 84% Digestive 93% GU 89% Ob-Gyn 78% Nervous 81% ENT 82% Eye 93% Dental 91% Dermatological 68% CA Palliative 80% Misc 81%

   
   

2. Summary of Russian SCENAR results published by Yori Gorfinkle, MD. Taganrog, Russia

Percent cured	84.91%
Percent Improved	94.75%
Average Treatments	12
Average total time (hours)	4.06
Total number of cases	17,309


Details:

Diseases of the Circulation System

	# Patients	Complete Cure	Significant Improvement	Moderate	Slight	No Result	% Cured	% Improved
Transient dystonia of blood vessels	682	614	38	10	12	8	90.03	98.83
Essential hypertension	318	261	13	22	8	14	82.08	95.60
Angina pectoris	228	138	42	8	13	14	60.53	88.16
Acute myocardial infarction	31	22	4	3	1	1	70.97	96.77
Sudden cardiac arrest	16	12	0	0	0	4	75.00	75.00
Acute heart failure	48	47	0	0	0	1	97.92	97.92
Ischemic heart disease	92	2	69	4	14	4	2.17	96.74
Cardialgia NOS	104	99	1	1	1	2	95.19	98.08
Hemorrhoids	408	391	14	1	1	1	95.83	99.75
Totals	1927	1586	181	49	50	49	72.46	96.83

Diseases of the Digestive System

	# Patients	Complete Cure	Significant Improvement	Moderate	Slight	No Result	% Cured	% Improved
Gastritis and duodenitis	1,018	1002	12	1	1	2	98.43	99.80
Gastric and Duodenal Ulcers	341	228	13	26	2	12	66.86	78.89
Enteritis (mainly non-infectious)	182	182	0	0	0	0	100	100
Colitis	302	263	20	10	3	6	87.09	98.01
Cholecystitis	218	145	6	10	3	4	66.51	75.23
Hepatitis/Hepatic Failure	48	47	0	0	0	1	97.92	97.92
Pancreatitis (Acute and Chronic)	63	63	0	0	0	0	100	100
Totals	2,172	1,930	51	47	9	25	88.86	93.78

Diseases of the ear

	# Patients	Complete Cure	Significant Improvement	Moderate	Slight	No Result	% Cured	% Improved
Otitis	144	144	0	0	0	0	100	100
Hearing Loss	85	68	11	4	0	2	80.00	97.65
Abnormal auditory perception	116	98	4	2	4	8	84.48	93.10
Totals	345	310	15	6	4	10	89.86	97.10

Diseases & Trauma of Musculoskeletal System

	# Patients	Complete Cure	Significant Improvement	Moderate	Slight	No Result	% Cured	% Improved
Arthropathies (arthritis, arthrosis, etc.	1,238	753	280	114	61	30	60.82	97.58
Dorsopathies (deformations, spondylosis)	2,352	2,048	252	35	17	2	87.07	100
Radiculopathy (trapped nerve)	1,820	1,670	102	40	6	2	91.76	99.89
Neuralgia (cervicalgia, lumbago, sciatica)	605	582	17	6	0	0	96.20	100
Myositis	840	839	0	0	0	1	99.88	99.88
Ligament strain	108	108	0	0	0	0	100	100
Superficial injury of soft tissues	325	325	0	0	0	0	100	100
Unknown pain (soft tissues and bones)	32	28	1	1	1	1	87.50	96.88
Totals	7,320	6,353	652	196	85	36	90.40	99.54

Diseases of Respiratory System

	# Patients	Complete Cure	Significant Improvement	Moderate	Slight	No Result	% Cured	% Improved
Acute nasopharyngitis (common cold)	608	601	6	0	0	1	98.85	99.84
Acute upper respiratory viral infection	345	345	0	0	0	0	100	100
Influenza	104	104	0	0	0	0	100	100
Acute Tonsillitis and pharyngitis	328	314	14	0	0	0	95.73	100
Acute Sinusitis	221	218	3	0	0	0	98.64	100
Acute Laryngitis and traceitis	402	380	18	2	0	0	94.53	99.50
Acute Bronchitis	615	562	24	15	7	7	91.38	98.86
Pneumonia	138	116	14	2	3	3	84.06	97.83
Asthma	82	31	15	22	7	7	37.80	91.46
Acute respiratory failure	15	14	0	0	0	1	93.33	93.33
Actue edema of the lung	12	11	0	0	0	1	91.67	91.67
Pleurisy	38	22	2	1	1	1	86.84	97.37
Totals	2,908	2,729	96	42	18	21	89.40	99.20

Urogenital Diseases (Female)

	# Patients	Complete Cure	Significant Improvement	Moderate	Slight	No Result	% Cured	% Improved
Mastopathy	264	220	8	16	3	18	83.33	93.56
Acute Mastitis	88	88	0	0	0	0	100	100
Salpingitis/ovarian cyst	608	604	1	1	1	1	99.34	99.84
Endometriosis	126	98	4	10	7	7	77.78	94.44
Fibromyoma of uterus	201	116	38	21	3	23	57.71	88.56
Erosion of cervix uteri	120	119	0	0	0	1	99.71	99.17
Dysmenorrhea (menstrual cycle disorders)	180	112	30	12	0	26	62.22	85.56
Female infertility	86	63	0	0	0	23	73.26	73.26
Frigidity	38	18	6	7	1	6	47.37	84.21
Totals	1,711	1,438	87	67	15	105	77.11	93.92

Urogenital Diseases (Male)

	# Patients	Complete Cure	Significant Improvement	Moderate	Slight	No Result	% Cured	% Improved
Pyelonephritis (Acute and Chronic)	402	384	4	7	3	4	95.52	99.00
Urinary calculi	161	140	7	6	5	3	86.96	98.14
Cystitis	208	207	0	0	0	1	99.52	99.52
Urethritis	24	22	1	0	0	1	91.67	95.83
Prostatitis (Acute and Chronic)	605	602	3	0	0	1	99.50	100
Hyperplasia of prostate	88	63	7	3	8	7	71.59	92.05
Male infertility	62	44	0	0	0	18	70.97	70.97
Impotence	322	269	14	0	0	48	80.75	85.09
Totals	1,872	1,731	36	16	16	83	87.06	92.58





In Europe and USA the Acuscen is registered as the following device:

Europe:

Various SCENAR models has been awarded the CE mark and complies with the European Medical Directive (93/42/EEC). This documentation states it is:

A device for monitoring, treating and alleviating non-specific disease, injury or handicap by supplying low-level electrical energy to the body system in a form that may reduce pain, oedema and inflammation in a manner that allows the natural resources of that body to restore homeostasis more rapidly than if it were left alone......(by) electrical action on the skin surface activating tissues in the "somatic and autonomous" nervous system...(leading to) the possibility of a therapeutic effect in addition to mediating pain by the production of endorphins. In simple terms, SCENAR Treatment is currently permitted to claim positive efficacy for pain relief and pain management for to use in all countries in the European Union, and is a 'safe device'.

USA:

SCENAR Biofeedback-controlled. Regulated by the US FDA under 21 CFR 882.5050, Generic Name: Device, Biofeedback, Product Code HCC, Class II exempt from 510(K) pre-market notification according to FDA Notice FR21ja98-84 as a battery-powered, professional use device for relaxation training and muscle education. A Class III FDA approval is pending. Prior to that approval, the manufacturer can only promote use for above in the US.